Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 131

1. Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata Drug Design Development and Therapy · 2022 · 49 citations
2. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
3. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023 · 6 citations
4. Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2 Dermatology and Therapy · 2023 · 1 citations
5. Journal of Population Therapeutics and Clinical Pharmacology 2025
6. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
7. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
8. Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review Frontiers in Immunology · 2026
9. When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review Journal of Dermatological Treatment · 2025
10. Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients Australasian Journal of Dermatology · 2024

Community

— no results